# Hemab Therapeutics Holdings, Inc.: Form 8-K, filed Sep 24, 2026

- Company: [Hemab Therapeutics Holdings, Inc.](/companies/coag.md) (CIK 2114044)
- Form: 8-K
- Filed: 2026-09-24
- Accepted by EDGAR: Sep 24, 2026, 16:03 ET
- Period: 2026-09-24
- Accession: 0001193125-26-401010
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/2114044/000119312526401010/d35700d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/2114044/000119312526401010/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/2114044/000119312526401010/d35700d8k.htm

Filed Sep 24, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-401010. Last ingested by Listed: Nov 11, 2026, 00:15 ET. No prices; not investment advice.